Overview

Weight Loss With Risedronate for Bone Health

Status:
Completed
Trial end date:
2020-07-22
Target enrollment:
Participant gender:
Summary
This is a pilot project to determine the feasibility of recruiting, enrolling, treating, and following 24 older sleeve gastrectomy patients into a randomized controlled trial (RCT) examining the efficacy of bisphosphonate use versus placebo in the prevention of surgical weight loss associated loss of bone mass and quality.
Phase:
Phase 4
Details
Lead Sponsor:
Wake Forest University Health Sciences
Collaborator:
Wake Forest University
Treatments:
Etidronic Acid
Risedronate Sodium
Risedronic Acid